Voltar
Revisão Revisado por pares
BIBTEX RIS

Adenosine antagonists

1989; Wiley; Volume: 9; Issue: 2 Linguagem: Italiano

10.1002/med.2610090205

ISSN

1098-1128

Autores

Michael Williams,

Tópico(s)

Synthesis and Biological Evaluation

Resumo

Medicinal Research ReviewsVolume 9, Issue 2 p. 219-243 Article Adenosine antagonists Michael Williams, Michael Williams Research Department, Pharmaceutical Division, CIBA-GEIGY, Summit, New Jersey 07901 Michael Williams: graduated in Biochemistry from Chelsea College, University of London in 1971. He gained a Ph.D. in Neurochemistry and an abiding interest in adenosine function at the Institute of Psychiatry, London, in 1974. Following a postdoctoral period at the University of North Carolina, Chapel Hill, he joined the Neuropsychopharmacology Group at Merck, Sharp and Dohme, West Point, PA in 1976 where he worked in the dopamine, GABA, neurotensin, adenosine, and serotonin research areas. In 1983, he joined the newly formed Nova Pharmaceutical Corporation in Baltimore and helped establish the Biological Research Division. In 1984, he left to join CIBA-GEIGY in Summit, NJ where he is currently Assistant Director. He was recently (1987) awarded the D.Sc. degree in Pharmacology from the University of London.Search for more papers by this author Michael Williams, Michael Williams Research Department, Pharmaceutical Division, CIBA-GEIGY, Summit, New Jersey 07901 Michael Williams: graduated in Biochemistry from Chelsea College, University of London in 1971. He gained a Ph.D. in Neurochemistry and an abiding interest in adenosine function at the Institute of Psychiatry, London, in 1974. Following a postdoctoral period at the University of North Carolina, Chapel Hill, he joined the Neuropsychopharmacology Group at Merck, Sharp and Dohme, West Point, PA in 1976 where he worked in the dopamine, GABA, neurotensin, adenosine, and serotonin research areas. In 1983, he joined the newly formed Nova Pharmaceutical Corporation in Baltimore and helped establish the Biological Research Division. In 1984, he left to join CIBA-GEIGY in Summit, NJ where he is currently Assistant Director. He was recently (1987) awarded the D.Sc. degree in Pharmacology from the University of London.Search for more papers by this author First published: April/June 1989 https://doi.org/10.1002/med.2610090205Citations: 35 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 G. A. Spiller, Prog. Clin. Biol. Res., 158, 1 (1984). 2 J. J. Barrone and H. Roberts, in Caffeine, P. B. Dews (Ed.), Springer-Verlag, New York. 1984, p. 59. 3 R. M. Gilbert, in Nutrition and Behavior, S. A. Miller (Ed.), Franklin Institute Press, Phildelphia, 1981, p. 145. 4 D. M. Graham, Nutr. Rev., 36, 774 (1978). 5 S. H. Snyder, Ann. Rev. Neurosci., 8, 103 (1985). 6 A. Sollevi, Prog. Neurobiol., 27, 319 (1986). 7 M. J. Cusheley, A. E. Tattersfield, and S. T. Holgate, Am. Rev. Respir. Disc., 129, 380 (1984). 8 H. Osswald, Trends Pharmacol. Sci., 5, 94 (1984). 9 H. Hidaka, T. Tanaka, and H. Itoh, Trends Pharmacol. Sci., 5, 237 (1984). 10 P. F. Worley, J. M. Baraban, and S. H. Snyder, Ann. Neurol., 21, 217 (1984). 11 W. C. Bowman and M. J. Rand, Textbook of Pharmacology, 2d Ed., Blackwell, Oxford, 1980, p. 223. 12 C. Lugnier, Biochem. Pharmacol., 35, 1743 (1986). 13 B. Waldeck, in Anti-Asthma Xanthines and Adenosine K.-E. Andersson and C. G. A. Persson (Eds.), Excerpta Medica, Amsterdam, 1985, p. 184. 14 G. Fassina, R. M. Gaion, L. Caparrotta, and F. Carpenedo, Naunyn-Schmideberg's Arch, Pharmacol., 330, 222 (1985). 15 W. T. Clusin, Nature (Lond.), 301, 248 (1983). 16 M. J. Peach, Proc. Natl. Acad. Sci. USA, 69, 834 (1972). 17 K.-E. Andersson, in Anti-asthma Xanthines and Adenosine, K.-E. Andersson and C. G. A. Persson (Eds.), Excerpta Medica, Amsterdam, 1985, p. 311. 18 U. Elben and R. Schroder, Arnzeim. Forsch., 34, 253 (1984). 19 B. Samuelsson, Science, 220, 568 (1983). 20 A. R. Whorton, J. B. Collawn, M. E. Montgomery, S. L. Young, and R. S. Kent, Biochem. Pharmacol., 34, 119 (1985). 21 A. Sattin and T. W. Rall, Mol. Pharmacol., 6, 13 (1970). 22 A. N. Drury and A. Szent-Gyorgyi, J. Physiol. (Lond.), 68, 213 (1929). 23 R. M. Honey, W. T. Ritchie, and W. A. R. Thomson, Quart. J. Med., 23, 485 (1930). 24 J. R. S. Arch and E. A. Newsholme, Essays Biochem., 14, 82 (1978). 25 G. Burnstock and C. Kennedy, Gen. Pharmacol., 16, 433 (1985). 26 S. Kakiuchi, T. W. Rall, and H. McIllwain, J. Neurochem., 16, 485 (1969). 27 J. W. Daly, J. Med. Chem., 25, 197 (1982). 28 T. V. Dunwiddie, Intern. Rev. Neurobiol., 27, 63 (1985). 29 M. Williams, Ann. Rev. Pharmacol. Toxicol., 27, 315 (1987). 30 C. Londos, J. Wolff, and D. F. M. Cooper, in Regulatory Function of Adenosine, R. M. Berne, T. W. Rall, and R. Rubio (Eds.), Nijhoff, Boston, 1983, p. 17. 31 R. J. Haslam, M. M. L. Davidson, and T. V. Desjardins, Biochem. J., 176, 83 (1978). 32 D. Van Calker, M. Muller, and B. Hamprecht, J. Neurochem., 33, 999 (1979). 33 B. Hamprecht and D. Van Calker, Trends Pharmacol. Sci., 6, 153 (1985). 34 T. W. Stone, in Purines: Pharmacology and Physiological Roles, T. W. Stone (Ed.), Macmillan, London, 1985, p. 1. 35 B. Fredholm and T. V. Dunwiddie, Trends Pharmacol. Sci., 9, 130 (1988). 36 E. B. Hollingsworth R. De La Cruz, and J. W. Daly, Eur. J. Pharmacol., 122, 45 (1986). 37 T. M. Delahunty and J. Linden, FASEB J., 2A 1132 (1988). 38 J. P. Green, Trends Pharmacol. Sci., 8, 90 (1987). 39 R. F. Bruns, Can. J. Physiol. Pharmacol., 58, 673 (1980). 40 U. Schwabe and T. Trost, Naunyn-Schmideberg's Arch. Pharmacol., 313, 179 (1980). 41 W. H. Moos, D. S. Szotek, and R. F. Bruns, J. Med. Chem., 28, 1383 (1985). 42 R. F. Bruns, J. W. Daly, and S. H. Snyder, Proc. Natl. Acad. Sci. USA, 77, 5547 (1980). 43 A. J. Bridges, R. F. Bruns, D. F. Ortwine, S. R. Priebe, D. L. Szotek, and B. K. Trivedi, J. Med. Chem., 31, 1282 (1988). 44 K. M. M. Murphy and S. H. Snyder, Mol. Pharmacol., 22, 250 (1982). 45 B. B. Fredholm, B. Jonzon, E. Lingren, and K. Lindstrom, J. Neurochem., 39, 165 (1982). 46 J. W. Ferkany, H. Valentine, G. A. Stone, and M. Williams, Drug Dev. Res., 9, 85 (1986). 47 G. A. Stone, M. F. Jarvis, M. A. Sills, B. A. Weeks, E. W. Snowhill, and M. Williams, Drug Dev. Res., 15, 31 (1988). 48 R. R. Goodman and S. H. Snyder, J. Neurosci., 2, 1230 (1982). 49 F. O. Schmitt, in Molecular Genetic Neuroscience, F. O. Schmitt, S. J. Bird and F. E. Bloom (Eds.), Raven, New York, 1982, p. 1. 50 R. F. Bruns, G. H. Lu, and T. A. Pugsley, Mol. Pharmacol., 29, 331 (1986). 51 J. A. Riberio and A. M. Sebastio, Prog. Neurobiol., 26, 179 (1986). 52 R. F. Bruns, Biochem. Pharmacol., 30, 325 (1981). 53 B. K. Trivedi, A. J. Bridges, and R. F. Bruns, in The Adenosine Receptors, M. Williams (Ed.), Humana Press, Clifton, NJ, (1989). 54 P. H. Wu, J. W. Phillis, and M. J. Nye, Life Sci., 31, 2857 (1982). 55 J. W. Daly, P. Butts-Lamb, and W. Padgett, Cell. Mol. Neurobiol., 3, 69 (1983). 56 J. W. Daly, W. Padgett, M. T. Shamim, P. Butts-Lamb, and J. Waters, J. Med. Chem., 28, 487 (1985). 57 U. Schwabe, D. Ukena, and M. J. Lohse, Naunyn-Schmiedeberg's Arch. Pharmacol., 330, 212 (1985). 58 J. W. Daly, W. L. Padgett, and M. T. Shamim, J. Med. Chem., 29, 1305 (1986). 59 J. W. Daly, W. L. Padgett, and M. T. Shamim, J. Med. Chem., 29, 1520 (1986). 60 D. Ukena, M. T. Shamim, W. Padgett, and J. W. Daly, Life Sci., 39, 743 (1986). 61 F. W. Smellie, C. W. Davis, J. W. Daly, and J. N. Wells, Life Sci., 24, 2475 (1979). 62 R. F. Bruns, J. W. Daly, and S. H. Snyder, Proc. Natl. Acad. Sci. USA, 80, 2077 (1983). 63 H. H. Hamilton, D. F. Ortwine, D. F. Worth, E. W. Badger, J. A. Bristol, R. F. Bruns, S. J. Haleen, and R. P. Steffen, J. Med. Chem., 28, 1071 (1985). 64 M. T. Shamim, D. Ukena, W. L. Padgett, O. Hong, and J. W. Daly, J. Med. Chem., 31, 613 (1988). 65 K. A. Jacobson, K. L. Kirk, W. L. Padgett, and J. W. Daly, J. Med. Chem., 28, 1341 (1985). 66 K. A. Jacobson, K. L. Kirk, W. L. Padgett, and J. W. Daly, Mol. Pharmacol., 29, 126 (1986). 67 K. A. Jacobson, in Adenosine Receptors, D. M. F. Cooper and C. Londos (Eds.), Liss, New York, 1988, p. 1. 68 J. Linden, A. Patel, C. Q. Earl, R. H. Craig, and S. M. Daluge, J. Med. Chem., 31, 745 (1988). 69 S. M. Daluge and H. J. Leighton, Eur. Patent 203721 (1986). 70 R. F. Bruns, R. E. Davis, F. W. Ninteman, B. P. H. Poschel, J. N. Wiley, and T. G. Heffner, in Adenosine and Adenine Nucleotides: Physiology and Pharmacology, D. M. Paton (Ed.), Taylor and Francis, London, 1988, p. 39. 71 K. S. Lee and M. Reddington, Brain Res., 368, 394 (1986). 72 M. Williams, E. A. Risley, and J. R. Huff, Can. J. Physiol. Pharmacol., 59, 897 (1981). 73 A. Czernik, B. Petrack, H. J. Kalinsky, S. Psychoyos, W. D. Cash, C. Tsai, R. K. Rinehart, F. R. Granat, R. A. Lovell, D. E. Brundish, and R. Wade, Life Sci., 30, 363 (1982). 74 M. Williams, Prog. Neurobiol. Biol. Psychiatr., 8, 209 (1984). 75 M. Williams and M. F. Jarvis, Pharmacol. Biochem. Behav., 29, 433 (1988). 76 L. P. Davies, S. Choi, J. H. Skerritt, D. J. Brown, and G. A. R. Johnston, Life Sci., 34, 2117 (1984). 77 R. Sarges, U. S. Patent, 4547501 (1985). 78 M. R. Goldberg, P. W. Curalto, C. S. Tung, and D. Robertson, Neurosci. Letts., 31, 47 (1982). 79 R. M. Green and G. L. Stiles, J. Clin. Invest., 77, 222 (1986). 80 B. Trivedi and R. F. Bruns, J. Med. Chem., 31, 1011 (1988). 81 R. A. Olsson, E. M. Khouri, J. L. Bedynek, Jr., and J. McLean, Circ. Res., 45, 468 (1979). 82 M. Williams, J. E. Francis, G. R. Ghai, A. Braunwalder, S. Psychoyos, G. A. Stone, and W. D. Cash, J. Pharmacol. Exp. Ther., 241, 415 (1987). 83 J. E. Francis, W. D. Cash, S. Psychoyos, G. Ghai, P. Wenk, R. C. Friedmann, C. Atkins, V. Warren, P. Furness, J. L. Hyun, G. A. Stone, M. Desai, and M. Williams, J. Med. Chem., 31, 1014 (1988). 84 R. F. Bruns and L. Coughenour, Pharmacologist, 29, 146 (1987). 85 H. W. Hamilton, D. F. Ortwine, D. F. Worth, and J. A. Bristol, J. Med. Chem., 30, 91 (1987). 86 Y. Watanabe, R. T. Lai, and H. Yoshida, Eur. J. Pharmacol., 86, 265 (1983). 87 R. T. Lai, Y. Watanabe, Y. Kamino, and H. Yoshida, Life Sci., 34, 409 (1984). 88 M. Williams and E. A. Risley, Proc. Natl. Acad. Sci. U.S.A., 77, 6892 (1980). 89 W. J. Parsons, V. Ramkumar, and G. L. Stiles, Mol. Pharmacol., 33, 441 (1988). 90 D. Ukena, K. A. Jacobson, K. L. Kirk, and J. W. Daly, FEBS Letts., 199, 269 (1986). 91 K. A. Jacobson, D. Ukena, K. L. Kirk, and J. W. Daly, Proc. Natl. Acad. Sci. USA, 83, 4089 (1986). 92 M. F. Jarvis, K. A. Jacobson, and M. Williams, Neurosci. Letts., 81, 69 (1987). 93 R. F. Bruns, J. H. Fergus, E. W. Badger, J. A. Bristol, L. A. Santay, J. D. Hartman, S. J. Hays, and C. C. Huang, Naunyn-Schmiedeberg's Arch. Pharmacol., 335, 59 (1987). 94 R. F. Bruns, J. H. Fergus E. W. Badger, J. A. Bristol, L. A. Santay, and S. J. Hays, Naunyn-Schmiedeberg's Arch. Pharmacol., 335, 64 (1987). 95 A. Patel, R. H. Craig, S. M. Daluge, and J. Linden, Mol. Pharmacol., 33, 585 (1988). 96 M. F. Jarvis, G. A. Stone, M. A. Sills, and M. Williams, Pharmacologist, 30, A210 (1988). 97 G. Burnstock and C. H. V. Hoyle, Br. J. Pharmacol., 85, 291 (1985). 98 M. Williams, M. F. Jarvis, M. A. Sills, J. W. Ferkany, and A. Braunwalder, Biochem. Pharmacol., 36, 4024 (1987). 99 K. S. Lee, P. Schubert, M. Reddington, and G. Kreutzberg, Acta Histochimica Suppl. 31, 45 (1985). 100 A. Verma and P. J. Marangos, Life Sci., 36 283 (1985). 101 J. M. Carney, L. Logan, J. B. McMaster, and T. W. Seale, in Adenosine: Receptors and Modulation of Cell Function, V. Stefanovich, K. Rudolphi, and P. Schubert (Eds.), IRL Press, Oxford, U. K., 1985, p. 199. 102 M. F. Jarvis and M. Williams, Pharmacol. Biochem. Behav., 30, 707 (1988). 103 M. G. Collis, J. C. Culver, and S. Holmes. Br. J. Pharmacol, 94, 423 (1988). 104 J. W. Daly, in Purines, Pharmacology and Physiological Roles, T. W. Stone, (Ed.), Macmillan, London, 1985, p. 5. 105 R. A. Olsson, R. D. Thompson, and S. Kusachi, in Methods In Pharmacology, 6, Methods Used In Adenosine Research, D. M. Paton (Ed.), Plenum, New York, 1985, p. 293. 106 A. S. Clanachan, Can. J. Physiol. Pharmacol., 59, 603 (1981). 107 T. W. Rall, in The Pharmacological Basis of Therapeutics, 7th Ed. A. G. Gilman, L. S. Goodman, T. W. Rall, and F. Murad (Eds.), Macmillan, New York, 1985, p. 589. 108 H. H. Harms, G. Wardeh, and A. H. Mulder, Eur. J. Pharmacol., 49, 305 (1978). 109 M. Williams, Trends Neurosci., 7, 164 (1984). 110 J. M. Gidday, S. W. Ely, J. W. Ester, and R. M. Berne, Fed. Proc., 43, 1084 (1984). 111 H. R. Winn, R. Rubio, and R. M. Berne, Circ. Res., 45, 486 (1979). 112 C. G. A. Persson, in Adenosine and Adenine Nucleotides: Physiology and Pharmacology, D. M. Paton (Ed.), Taylor and Francis, London, 1988, p. 217. 113 D. W. Yesair, A. R. Branfman, and M. M. Callahan, Prog. Clin. Biol. Res., 158, 215 (1984). 114 E. M. Laska, A. Sunshine, F. Muller, W. B. Elvers, C. Siegal, and A. Rubin. JAMA, 251, 1711 (1984). 115 M. Radulovacki, R. M. Virus, D. Rapoza, and R. C. Crane, Neuropharmacology, 24, 547 (1985). 116 G. L. Louie, P. G. Prokociemer, E. A. Nicholls, and M. Maze, Brain Res., 383, 377 (1986). 117 A. Nehlig, G. Luicignani, M. Kadekaro, L. J. Porrino, and L. Sokoloff, Eur. J. Pharmacol., 101, 91 (1984). 118 I. Hindmarch and Z. Subhan, Drug Dev. Res., 5, 379 (1985). 119 D. S. Charney, G. R. Heninger, and P. I. Jatlow, Arch. Gen. Psychiatr., 42, 233 (1985). 120 J. W. Phillis and M. H. O'Regan, Prog. Neuropsychopharmacol. Biol. Psychiatr., 12, 389 (1988). 121 J. W. Phillis and M. H. O'Regan, Trends Pharmacol. Sci., 9, 153 (1988). 122 M. Dragunow, G. V. Goddard, and R. Laverty, Epilepsia, 26, 280 (1985). 123 M. Dragunow, Prog. Neurobiol., 31, 85 (1988). 124 P. H. Franklin, E. D. Tripp, G. Zhang, K. Gale, and T. F. Murray, Eur. J. Pharmacol., 150, 207 (1988). 125 I. K. Ho, H. H. Lo, and E. L. Way, J. Pharmacol. Exp. Ther., 185, 336 (1973). 126 H. Vapaatalo, D. Onken, P. J. Neuvonen, and E. Westermann, Arzneim. Forsch., 25, 407 (1975). 127 G. G. Yarbrough and J. J. McGuffin-Clineschmidt, Eur. J. Pharmacol., 76, 137 (1981). 128 H. O. J. Collier, N. J. Cuthbert, and D. L. Francis, Fed. Proc., 40, 1513 (1981). 129 M. Galloway and R. H. Roth, J. Pharmacol. Exp. Ther., 227, 1 (1983). 130 B. B. Fredholm, M. Herrana-Maschwitz, B. Jonzon, K. Lindstrom, and U. Ungerstedt, Pharmacol. Biochem. Behav., 19, 535 (1983). 131 J. J. Katims, Z. Annau, and S. H. Snyder, J. Pharmacol. Exp. Ther., 227, 167 (1983). 132 T. W. Seale, K. A. Abla, M. T. Shamim, J. M. Carney, and J. W. Daly, Life Sci., 43, 1671 (1988). 133 K. Fuxe and U. Ungerstedt, Med. Biol., 52, 48 (1974). 134 R. D. Green, H. K. Proudfit, and S-H. Yeung, Science, 218, 58 (1982). 135 E. M. Boyd, M. Dolman, L. M. Knight, and E. P. Sheppard, Can. J. Physiol. Pharmacol., 43, 995 (1965). 136 K. G. Lloyd, O. Hornykiewicz, L. Davidson, K. Shannak, I. Farley, M. Goldstein, M. Shibua, W. N. Keller, and I. H. Fox, N. Engl. J. Med., 305, 1106 (1981). 137 H. Criswell, R. A. Mueller, and G. R. Breese, J. Pharmacol. Exp. Ther., 244, 493 (1988). 138 T. G. Heffner, D. A. Downs, J. A. Bristol, R. F. Bruns, S. E. Harrigan, W. H. Moos, K. L. Sledge, and J. N. Wiley, Pharmacologist, 27, 293 (1985). 139 M. F. Losonczy, M. Davidson, and K. L. Davis, in Psychopharmacology: A Third Generation of Progress, H. Y. Meltzer (Ed.), Raven, New York, 1987, p. 715. 140 R. H. Roth, Ann. N. Y. Acad. Sci., 430, 27 (1984). 141 M. Newman, J. Zohar, M. Kalian, and R. H. Belmaker, Brain Res., 291, 188 (1984). 142 T. W. Stone, in Regulatory Function of Adenosine, R. M. Berne, T. W. Rall and R. Rubio (Eds.), Nijhoff, Boston, 1983, p. 467. 143 H. Lagercrantz, C. Yamamoto, B. B. Fredholm, N. Prabhakar, and C. Euler, Pediatr. Res., 18, 387 (1984). 144 J. V. Arnada and T. Turmen, Clin. Perinatol., 6, 87 (1979). 145 R. M. Berne, in Adenosine: Receptors and Modulation of Cell Function, V. Stefanovich, K. Rudolphi, and P. Schubert (Eds.), IRL Press, Oxford, U. K., 1985, p. 357. 146 E. Skinhoj and O. B. Paulsen, Acta Neurol. Scand., 46, 129 (1970). 147 J. W. Phillis and R. E. DeLong, J. Pharm. Pharmacol., 38, 460 (1986). 148 A. Sollevi, L. Torssell, A. Owall, A. Edlund, and M. Lagerkranser in Topics and Perspectivs in Adenosine Research, E. Gerlach and B. F. Becker, Eds., Springer Verlag, Berlin, 1987, p. 599. 149 J. J. Grome and V. Stefanovich, Naunyn-Schmiedeberg's Arch. Pharmacol., 333, 172 (1986). 150 E. Lunell, K.-E. Andersson, and C. G. A. Persson, Acta Pharmacol. Toxicol., 53, 205 (1983). 151 G. Burnstock, J. Cardiovasc. Pharmacol., 7, 5137 (1985). 152 L. Bellardinelli and, G. A. West, and S. H. F. Clemo, in Topics and Perspectives in Adenosine Research, Springer Verlag, Berlin, 1987, p. 344. 153 G. A. West, W. Giles, and L. Belardinelli, in Topics and Perspectives in Adenosine Research, Springer Verlag, Berlin, 1987, p. 336. 154 R. I. Ogilvie, in Anti-Asthma Xanthines and Adenosine, K.-E. Andersson and C. G. A. Persson (Eds.), Excerpta Medica, Amsterdam, 1985, p. 327. 155 C. G. A. Persson, in Anti-Asthma Xanthines and Adenosine, K.-F. Andersson and C. G. A. Persson (Eds.), Excerpta Medica, Amsterdam, 1985, p. 61. 156 N. Svedmyr in Anti-Asthma Xanthines and Adenosine, K.-E. Andersson and C. G. A. Persson (Eds.), Excerpta Medica, Amsterdam, 1985, p. 135. 157 E. Lunell, N. Svedmyr, K.-E. Andersson, and C. G. A. Persson, Eur. J. Clin. Pharmacol., 22, 395 (1982). 158 S. T. Holgate, M. J. Cushley, P. Rafferty, R. Beasley, G. Phillips, and M. K. Church, in Topics and Perspectives in Adenosine Research, E. Gerlach and B. F. Becker, Eds., Springer Verlag, Berlin, 1987, p. 614. 159 A. Koschaloff, Virchows Arch. Abt. A. Pathol. Anat., 31, 436 (1964). 160 S. Itoh, O. A. Carretero, and R. D. Murray, J. Clin. Invest., 76, 1412 (1985). 161 R. D. Murray and P. C. Churchill, J. Pharmacol. Exp. Ther., 232, 189 (1985). 162 M. G. Collis, G. S. Baxter, and J. R. Keddie, J. Pharm. Pharmacol., 38, 850 (1986). 163 T. A. Waldmann, in Immunological Diseases, 4th Ed, M. Samter, D. W. Talmage, M. M. Frank, K. F. Austen, and H. N. Claman (Eds.), Little Brown, Boston, 1988, p. 411. 164 B. N. Cronstein and R. Hischhorn, in The Adenosine Receptors M. Williams (Ed.), Humana Press, Clifton, NJ, in press (1989). 165 M. K. Samet, Life Sci., 37, 225 (1985). 166 M. Williams and G. L. Neil, Prog. Drug. Res., 32, 329 (1988). Citing Literature Volume9, Issue2April/June 1989Pages 219-243 ReferencesRelatedInformation

Referência(s)